A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to evaluate the effect of lanabecestat on rosuvastatin. The amount of rosuvastatin in the blood will be compared, when taken alone, and then when taken with lanabecestat. The amount of lanabecestat that gets into the bloodstream will be measured. Information about any side effects that may occur will also be collected. Participants will be on study for 21 days with a follow-up at least 7 days afterwards. Screening will be undertaken within 45 days prior to enrollment.

Key facts

Study ID
NCT03019549
Run by
AstraZeneca
People needed
42
Starts
2017-01-12
Expected to finish
2017-05-22
Last updated by the study team
2019-11-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.